The life sciences industry needs a shot of adrenaline. An aging population and a rise in chronic diseases are fueling the ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is a clinical-stage biotechnology company integrating artificial intelligence ...

Ten stocks took a beating on Wednesday, mimicking a mostly pessimistic broader market, as investors repositioned portfolios ...

The U.S. is engaged in various activities from international deportation agreements to tackling AI-induced job fears. Notable developments include Google's $30 million settlement over YouTube's child ...

Recent reports highlight uncertainty about pharmaceutical tariffs, an error-prone AI tool in use at the FDA, and research funding in jeopardy.

Faster access to medicines matters to patients. For many New Zealanders, pharmaceuticals are life or death, or the difference ...

Rob Abbott, CEO, ISPOR, highlights how AI is streamlining research and improving patient care while stressing the importance of human oversight.

Cell culture is a foundational technology widely used across fields such as pharmaceutical production, regenerative medicine, ...

As global director of healthcare and sciences at Google Cloud, Shweta Maniar is working with organizations to find ways to ...

Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines to discover and develop ...

Clinical supply chains are transforming, and so are the technological barriers to entry for firms in Life Sciences. To stay ...

Improved patient outcomes and safety: Ultimately, smarter learning powered by AI should lead to better care. More ...